New ASTM International Nanotechnology Standard Supports Drug Development

Drug manufacturers will be able to use a new ASTM International nanotechnology standard to help ensure quality control when developing drugs, including some that have the potential to be less toxic and more targeted. ASTM International’s nanotechnology committee (E56) created the new standard (E3143).

“Nanotechnology offers great promise for new drugs to treat a wide variety of illnesses,” says ASTM International member Debra Kaiser, senior advisor, office of data and informatics, National Institute of Standards and Technology.  “This standard will be used to advance the development of liposome nanomaterials, the largest class of nanomaterial-based drug products.”

CONTINUE READING ON www.astm.org